Shiranee Sriskandan

Shiranee Sriskandan

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
NLNicola N Lynskey
Nicola N Lynskey
EJElita Jauneikaite
Elita Jauneikaite
HLHo Kwong Li
Ho Kwong Li
XZXiangyun Zhi
Xiangyun Zhi
CTClaire Turner
Claire Turner
SSShiranee Sriskandan
Shiranee Sriskandan
Since 2014, England has seen increased scarlet fever activity unprecedented in modern times. In 2016, England's scarlet fever seasonal rise coincided with an unexpected elevation in invasive Streptococcus pyogenes infections. We describe the molecular epidemiological investigation of these events. We analysed changes in S pyogenes emm genotypes, and notifications of scarlet fever and invasive disease in 2014-16 using regional (northwest London) and national (England and Wales) data. Genomes of 135 non-invasive and 552 invasive emm1 isolates from 2009-16 were analysed and compared with 2800 global emm1 sequences. Transcript and protein expression of streptococcal pyrogenic exotoxin A (SpeA; also known as scarlet fever or erythrogenic toxin A) in sequenced, non-invasive emm1 isolates was quantified by real-time PCR and western blot analyses. Coincident with national increases in scarlet fever and invasive disease notifications, emm1 S pyogenes upper respiratory tract isolates increased significantly in northwest London in the March to May period, from five (5%) of 96 isolates in 2014, to 28 (19%) of 147 isolates in 2015 (p=0·0021 vs 2014 values), to 47 (33%) of 144 in 2016 (p=0·0080 vs 2015 values). Similarly, invasive emm1 isolates collected nationally in the same period increased from 183 (31%) of 587 in 2015 to 267 (42%) of 637 in 2016 (p<0·0001). Sequences of emm1 isolates from 2009-16 showed emergence of a new emm1 lineage (designated M1UK)-with overlap of pharyngitis, scarlet fever, and invasive M1UK strains-which could be genotypically distinguished from pandemic emm1 isolates (M1global) by 27 single-nucleotide polymorphisms. Median SpeA protein concentration in supernatant was nine-times higher among M1UK isolates (190·2 ng/mL [IQR 168·9-200·4]; n=10) than M1global isolates (20·9 ng/mL [0·0-27·3]; n=10; p<0·0001). M1UK expanded nationally to represent 252 (84%) of all 299 emm1 genomes in 2016. Phylogenetic analysis of published datasets identified single M1UK isolates in Denmark and the USA. A dominant new emm1 S pyogenes lineage characterised by increased SpeA production has emerged during increased S pyogenes activity in England. The expanded reservoir of M1UK and recognised invasive potential of emm1 S pyogenes provide plausible explanation for the increased incidence of invasive disease, and rationale for global surveillance. UK Medical Research Council, UK National Institute for Health Research, Wellcome Trust, Rosetrees Trust, Stoneygate Trust.

27 December 2007 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
SSShiranee Sriskandan
Shiranee Sriskandan
DADm Altmann
Dm Altmann
Sepsis, the systemic inflammatory response to infection, is considered the major cause of death among critically ill patients in the developed world. While there is a general view that this reflects contributions from both the pathogen and the host with respect to an inappropriate inflammatory response, there is a lack of agreement as to the key immune mechanisms. This has been reflected in the diverse range of immunotherapies tested in clinical trials, often with rather marginal effects. The case has been made for a pathogenic role of excessive immunity, the so‐called ‘cytokine storm’, and for a role of too little immunity through immune paralysis. Apoptosis is implicated as a key mechanism in both this immune paralysis and the multi‐organ failure that is a feature of severe sepsis. A number of polymorphisms have been implicated in susceptibility to sepsis, including cytokine genes, HLA class II and caspase‐12. In this review we focus in particular on the role of group A streptococci in severe sepsis. Here the effect of bacterial superantigens appears to be a correlate of inflammatory activation, although the precise evolutionary role of the superantigens remains unclear. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

18 May 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TPTom Parks
Tom Parks
CWClare Wilson
Clare Wilson
NCNigel Curtis
Nigel Curtis
ANAnna Norrby-Teglund
Anna Norrby-Teglund
SSShiranee Sriskandan
Shiranee Sriskandan
We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized studies.

3 May 2005 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PHP A Hopkins
P A Hopkins
SSShiranee Sriskandan
Shiranee Sriskandan

1 August 2008 in Cell Host & Microbe
Verified
Journal Article
Closed access
AZAnnelies S. Zinkernagel
Annelies S. Zinkernagel
ATAnjuli M. Timmer
Anjuli M. Timmer
MPMorgan A. Pence
Morgan A. Pence
JLJeffrey B. Locke
Jeffrey B. Locke
JBJohn T. Buchanan
John T. Buchanan
VNVictor Nizet
Victor Nizet

1 September 2005 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
RERobert J. Edwards
Robert J. Edwards
GTGraham W. Taylor
Graham W. Taylor
MFMelissa Ferguson
Melissa Ferguson
SMStephen Murray
Stephen Murray
NRNigel Rendell
Nigel Rendell
SSShiranee Sriskandan
Shiranee Sriskandan
Lethal necrotizing fasciitis caused by Streptococcus pyogenes is characterized by a paucity of neutrophils at the site of infection. Interleukin (IL)